Uses and limitations of fdg positron emission tomography in patients with head and neck cancer
β Scribed by Matthew M. Hanasono; Larisa D. Kunda; George M. Segall; Grace H. Ku; David J. Terris
- Book ID
- 110081979
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 686 KB
- Volume
- 109
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background A single institution study was undertaken to evaluate the role of positron emission tomography (PET) scans with fluorodeoxyglucose (FDG) prior to radiation and following radiation. ## Methods Fortyβfive patients with head and neck cancers were evaluated with FDGβPET sca
## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m
## Abstract __Background__. Positron emission tomography (PET) provides a noninvasive modality for evaluating the biochemical processes of normal and pathologic tissue. Preliminary reports of Fβ18 fluorodeoxyglucose (FDG) PET indicate its potential usefulness in evaluating head and neck tumors. The